CHCarmen Sara Hernández-Rodríguez

Carmen Sara Hernández-Rodríguez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Carmen Sara Hernández-Rodríguez has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Repeated field treatment selects for reduced susceptibility to acaricides in Varroa destructor

    by Sara Moreno‐Martí, Anabel Millán Leiva, Fernando Calatayud, Ana Mompó, Inmaculada Segura, Enrique Simó, Joel González‐Cabrera, Carmen Sara Hernández‐Rodríguez

    BACKGROUND: Varroa destructor control relies on a few synthetic acaricides, to which resistance is widespread. We assessed over 2 years how repeated field treatment with one acaricide changes mite susceptibility. Eighty honey bee colonies infested with one mite population of intermediate susceptibility were allocated by blocked randomization to coumaphos, amitraz, tau‐fluvalinate or oxalic acid (20 each), applied twice yearly after baseline sampling. Susceptibility was assessed before treatment (T0) and after two (T1) and four (T2) applications, using strip‐contact bioassays for coumaphos and amitraz and genotyping of the L925V mutation in the voltage‐gated sodium channel for pyrethroids. Data from 73 colonies (coumaphos, 16; amitraz, 20; tau‐fluvalinate, 19; oxalic acid, 18) were analyzed with linear mixed‐effects models. RESULTS: In coumaphos‐treated colonies, coumaphos bioassay mortality fell from 42% (95% confidence interval (CI) 36–48) at T0 to 21% (15–27) at T1 and 19% (10–27) at T2, a decline of 25–36 percentage points larger than in the other three treatments ( P ≤ 0.001). In tau‐fluvalinate‐treated colonies, the proportion of mites carrying at least one susceptible L925 allele fell from 33% (24–43) at T0 to 8% (4–15) at T1 and 6% (1–23) at T2, a change differing from every other treatment ( P ≤ 0.018). In amitraz‐treated colonies, amitraz bioassay mortality decreased from 86% (82–90) to 74% (69–79) at T2, a change differing only from coumaphos‐treated colonies. CONCLUSION: Four consecutive applications of coumaphos or tau‐fluvalinate within 2 years markedly reduced susceptibility to that compound, mostly after the first two applications. These results support acaricide rotation and regular susceptibility monitoring in V. destructor management. © 2026 Society of Chemical Industry.

  • Open Access

    A new mutation in the octopamine receptor associated with amitraz resistance in Varroa destructor

    by Carmen Sara Hernández‐Rodríguez, Sara Moreno‐Martí, Kristina Emilova‐Kirilova, Joel González‐Cabrera

    BACKGROUND: The acaricide amitraz is now used intensively in many regions to control the honey bee parasite, Varroa destructor, because of the reduced efficacy of pyrethroids and coumaphos caused by resistance evolution. The continued application of amitraz in recent years exerts a very high selection pressure on mites, favouring the evolution of resistance to this acaricide. Mutations N87S and Y215H in the β2‐adrenergic‐like octopamine receptor (Octβ2R), target site of amitraz, have been already associated with resistance to amitraz in France and the USA, respectively.RESULTS: A new mutation (F290L) in the Octβ2R of V. destructor has been found in mites from Spanish apiaries. The frequency of L290 mutated alleles in colonies increased after consecutive treatments with amitraz. In a field trial, mites from colonies with higher frequency of L290 mutated allele took longer to die compared with those carrying a higher proportion of the wild‐type allele. Lower susceptibility to amitraz was found in apiaries with a high frequency of homozygous mutants.CONCLUSION: Our data indicate the association of the F290L mutation in the octopamine receptor with resistance to amitraz in Spanish populations of V. destructor. Determining the frequency of mutant mites in apiaries may be important for predicting the efficacy of amitraz treatment in the field and would help design appropriate resistance management. © 2024 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.


  • Open Access

    Resistance to amitraz in the parasitic honey bee mite Varroa destructor is associated with mutations in the β-adrenergic-like octopamine receptor

    by Carmen Sara Hernández-Rodríguez, Sara Moreno-Martí, Gabrielle Almecija, Krisztina Christmon, Josephine D. Johnson, Marie Ventelon, Dennis Vanengelsdorp, Steven C. Cook, Joel González-Cabrera

    Varroa destructor is considered a major reason for high loss rate of Western honey bee (Apis mellifera) colonies. To prevent colony losses caused by V. destructor, it is necessary to actively manage the mite population. Beekeepers, particularly commercial beekeepers, have few alternative treatments other than synthetic acaricides to control the parasite, resulting in intensive treatment regimens that led to the evolution of resistance in mite populations. To investigate the mechanism of the resistance to amitraz detected in V. destructor mites from French and U.S. apiaries, we identified and characterized octopamine and tyramine receptors (the known targets of amitraz) in this species. The comparison of sequences obtained from mites collected from different apiaries with different treatment regimens, showed that the amino acid substitutions N87S or Y215H in the OctβR were associated with treatment failures reported in French or U.S. apiaries, respectively. Based on our findings, we have developed and tested two high throughput diagnostic assays based on TaqMan technology able to accurately detect mites carrying the mutations in this receptor. This valuable information may be of help for beekeepers when selecting the most suitable acaricide to manage V. destructor.


  • Open Access

    Resistance to amitraz in the parasitic honey bee mite Varroa destructor is associated with mutations in the β−adrenergic-like octopamine receptor

    by Carmen Sara Hernández-Rodríguez, Sara Moreno-Martí, Gabrielle Almecija, Krisztina Christmon, Josephine D. Johnson, Marie Ventelon, Dennis Vanengelsdorp, Steven C. Cook, Joel González-Cabrera

    Varroa destructor is considered a major reason for high loss rate of Western honey bee ( Apis mellifera ) colonies. To prevent colony losses caused by V. destructor it is necessary to actively manage the mite population. Beekeepers, particularly commercial beekeepers, have few alternative treatments other than synthetic acaricides to control the parasite, resulting in intensive treatment regimens that led to the evolution of resistance in mite populations. To investigate the mechanism of the resistance to amitraz detected in V. destructor mites from French and U.S. apiaries, we identified and characterized octopamine and tyramine receptors (the known targets of amitraz) in this species. The comparison of sequences obtained from mites collected from different apiaries with different treatment regimens, showed that the amino acid substitutions N87S or Y215H in the OctβR were associated with treatment failures reported in French or U.S. apiaries, respectively. Based on our findings, we have developed and tested two high throughput diagnostic assays based on TaqMan ® able to accurately detect mites carrying the mutations in this receptor. This valuable information may be of help for beekeepers when selecting the most suitable acaricide to manage V. destructor .


  • Open Access

    Large-Scale Monitoring of Resistance to Coumaphos, Amitraz, and Pyrethroids in Varroa destructor

    by Carmen Sara Hernández-Rodríguez, Óscar Marín, Fernando Calatayud, María José Mahiques, Ana Mompó, Inmaculada Segura, Enrique Simó, Joel González-Cabrera

    Varroa destructor is an ectoparasitic mite causing devastating damages to honey bee colonies around the world. Its impact is considered a major factor contributing to the significant seasonal losses of colonies recorded every year. Beekeepers usually rely on a reduced set of acaricides to manage the parasite, usually the pyrethroids tau-fluvalinate or flumethrin, the organophosphate coumaphos, and the formamidine amitraz. However, the evolution of resistance in the mite populations is leading to an unsustainable scenario with almost no alternatives to reach an adequate control of the mite. Here, we present the results from the first large-scale and extensive monitoring of the susceptibility to acaricides in the Comunitat Valenciana, one of the most prominent apicultural regions in Spain. Our ultimate goal is to provide beekeepers with timely information to help them decide what would be the best alternative for a long-term control of the mites in their apiaries. Our data show that there is a significant variation in the expected efficacy of coumaphos and pyrethroids across the region, indicating the presence of a different ratio of resistant individuals to these acaricides in each population. On the other hand, the expected efficacy of amitraz was more consistent, though slightly below the expected efficacy according to the label.


  • Open Access

    Large-scale monitoring of resistance to coumaphos, amitraz and pyrethroids in Varroa destructor

    by Carmen Sara Hernández-Rodríguez, Óscar Marín, Fernando Calatayud, María José Mahiques, Ana Mompó, Inmaculada Segura, Enrique Simó, Joel González-Cabrera

    Varroa destructor is an ectoparasitic mite causing devastating damages to honey bee colonies around the world. Its impact is considered a major factor contributing to the significant seasonal losses of colonies recorded every year. Beekeepers are usually relying on a reduced set of acaricides to manage the parasite, usually the pyrethroids tau-fluvalinate or flumethrin, the organophosphate coumaphos and the formamidine amitraz. However, the evolution of resistance in the populations is leading to an unsustainable scenario with almost no alternatives to reach an adequate control of the mite. Here we present the results from the first, large-scale and extensive monitoring of the susceptibility to acaricides in the Comunitat Valenciana, one of the most prominent apicultural regions in Spain. Our ultimate goal was to provide beekeepers with timely information to help them decide what would be the best alternative for a long-term control of the mites in their apiaries. Our data show that there is a significant variation in the expected efficacy of coumaphos and pyrethroids across the region, indicating the presence of a different ratio of resistant individuals to these acaricides in each population. On the other hand, the expected efficacy of amitraz was more consistent, although slightly below the expected efficacy according to the label. HIGHLIGHTS: Varroa destructor is causing severe damages to honey bee colonies worldwide. There are very few acaricides available to manage the parasite. The evolution of resistance is limiting our capacity to control the mite. We estimated the expected efficacy of the main acaricides in many Spanish apiaries. The information was shared with beekeepers for them to decide the best treatment to control the mite.

  • Assessing the resistance to acaricides in Varroa destructor from several Spanish locations

    by Mariano Higes, Raquel Martín-Hernández, Carmen Sara Hernández-Rodríguez, Joel González-Cabrera

    Varroosis is the disease caused by the ectoparasitic mite Varroa destructor, one of the most destructive diseases of honeybees. In Spain, there is great concern because there are many therapeutic failures after acaricide treatments intended to control varroosis outbreaks. In some of these cases it is not clear whether such failures are due to the evolution of resistance. Therefore, it is of high interest the development of methodologies to test the level of resistance in mite populations. In this work, a simple bioassay methodology was used to test whether some reports on low efficacy in different regions of Spain were in fact related to reduced Varroa sensitivity to the most used acaricides. This bioassay proved to be very effective in evaluating the presence of mites that survive after being exposed to acaricides. In the samples tested, the mortality caused by coumaphos ranged from 2 to 89%; for tau-fluvalinate, it ranged from 5 to 96%. On the other hand, amitraz caused 100% mortality in all cases. These results suggest the presence of Varroa resistant to coumaphos and fluvalinate in most of the apiaries sampled, even in those where these active ingredients were not used in the last years. The bioassay technique presented here, either alone or in combination with other molecular tools, could be useful in detecting mite populations with different sensitivity to acaricides, which is of vital interest in selecting the best management and/or acaricide strategy to control the parasite in apiaries.


  • Genetic variability and pyrethroid susceptibility of the parasitic honey bee mite Varroa destructor (Acari: Varroidae) in Iran

    by Mahsa Farjamfar, Alireza Saboori, Joel González-Cabrera, Carmen Sara Hernández Rodríguez

    The ectoparasitic honey bee mite Varroa destructor Anderson & Trueman (Acari: Varroidae) is one of the major concerns for worldwide beekeeping. The use of synthetic pyrethroids for controlling the mite was among the most popular treatments until resistance evolved in the mid 1990’s. In Iran, beekeepers are dealing with the parasite and they also used pyrethroids for controlling the mite for a long time. After the evolution of resistance to pyrethroids, they based mite control mostly on treatments with amitraz, organic acids and several management practices. Here we conducted a comprehensive characterization of V. destructor populations parasitizing Apis mellifera in Iran. We determined the genetic variability of mites collected from 28 localities distributed throughout the country. The haplotype of V. destructor was determined by PCR-RFLP, analyzing a fragment of the mitochondrial cox1 gene. It was found that only the Korean haplotype was present in samples from all localities. DNA fragments from cox1, atp6, cox3 and cytb mitochondrial genes were sequenced and the results showed that all samples were identical to the K1-1 or the K1-2 V. destructor haplotypes. Moreover, as it has been reported that resistance to pyrethroids in V. destructor is associated with mutations at position 925 of the voltage-gated sodium channel, a TaqMan®-based allelic discrimination assay was conducted to genotype the mites collected. The results showed that all the mites tested were homozygous for the wild-type allele and, therefore, susceptible to treatment with pyrethroids.


  • New PCR–RFLP diagnostics methodology for detecting Varroa destructor resistant to synthetic pyrethroids

    by Anabel Millán-Leiva, Carmen Sara Hernández-Rodríguez, Joel González-Cabrera


  • Insecticidal spectrum and mode of action of the Bacillus thuringiensis Vip3Ca insecticidal protein

    by Joaquín Gomis-Cebolla, Iñigo Ruiz de Escudero, Natalia Mara Vera-Velasco, Patricia Hernández-Martínez, Carmen Sara Hernández-Rodríguez, Tomás Ceballos, Leopoldo Palma, Baltasar Escriche, Primitivo Caballero, Juan Ferré